Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
The purpose of the study was to estimate the effectiveness of using ranibizumab in combination with medotilin drug in the treatment of neovascular age-related macular degeneration (AMD). Material and methods. 50 patients (65 eyes) aged 41 to 88 (ave. 68.5 ± 0.98 years) with neovascular AMD were foll...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Real Time Ltd
2018-10-01
|
Series: | Российский офтальмологический журнал |
Subjects: | |
Online Access: | https://roj.igb.ru/jour/article/view/69 |